Brief: Humanigen Confirms Notice Received From NIAID That They Have Completed Database Lock For Big Effect Trial Of Lenzilumab
June 30 (Reuters) - Humanigen Inc HGEN.O :
* HUMANIGEN - CONFIRMS NOTICE RECEIVED FROM NIAID THAT THEY
HAVE
COMPLETED DATABASE LOCK FOR BIG EFFECT TRIAL OF LENZILUMAB
* HUMANIGEN INC - NIH/NIAID HAS CLEANED AND LOCKED BLINDED
DATA IN
STUDY
* HUMANIGEN INC - EXPECTS TO RECEIVE TOPLINE RESULTS FROM
NIH/NIAID IN JULY
Source text for Eikon: ID:nBw6WcmqQa
Further company coverage: HGEN.O
Recent news on Humanigen
See all newsPress Digest: Wall Street Journal - Jan 5
Covid: 19 treatment developer Humanigen files for Chapter 11 bankruptcy
Brief: Humanigen Files For Voluntary Chapter 11 Bankruptcy - Court Filing
Brief: Covid-19 Treatment Developer Humanigen Files For Bankruptcy - WSJ
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners